Operative Management of Complications Following Intestinal Vaginoplasty: A Case Series and Systematic Review.

Urology

Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY; Department of Urology, NYU Langone Health, New York, NY. Electronic address:

Published: October 2023

Objective: To describe the authors' experience with surgical management of complications following intestinal vaginoplasty and review the literature on incidence of complications following gender-affirming intestinal vaginoplasty.

Methods: Retrospective chart review identified patients presenting with complications following prior intestinal vaginoplasty requiring operative management. Charts were analyzed for medical history, preoperative exam and imaging, intraoperative technique, and long-term outcomes. Systematic literature review was performed to identify primary research on complications following gender-affirming intestinal vaginoplasty.

Results: Four patients presented to the senior authors' clinic requiring operative intervention for complications following intestinal vaginoplasty, all of whom underwent surgical revision. Complications included vaginal stenosis (2 patients, 50%), vaginal false passage (1 patient, 25%), and diversion colitis (1 patient, 25%). Postoperatively all patients were able to dilate successfully to a depth of at least 15 cm. Systematic review identified 10 studies meeting inclusion criteria. There were 215 complications reported across 654 vaginoplasties (33% overall complication rate). Average return to operating room rate was 18%. The most common complications were stenosis (11%), mucorrhea (7%), vaginal prolapse (6%), and malodor (5%). Six intestinal vaginoplasty segments developed vascular compromise leading to flap loss. There were 2 reported mortalities.

Conclusion: Intestinal vaginoplasty is associated with a range of complications including vaginal stenosis, mucorrhea, and vaginal prolapse. Intra-abdominal complications, including diversion colitis, anastomotic bowel leak, and intra-abdominal abscess can occur many years after surgery, be life-threatening and require prompt diagnosis and management.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2023.07.005DOI Listing

Publication Analysis

Top Keywords

intestinal vaginoplasty
24
complications intestinal
12
complications
11
operative management
8
management complications
8
intestinal
8
systematic review
8
complications gender-affirming
8
gender-affirming intestinal
8
review identified
8

Similar Publications

Mesalamine as treatment of neovaginal ileitis: Case report and review of literature.

J Pediatr Adolesc Gynecol

December 2024

Department of Obstetrics and Gynecology, Pediatric and Adolescent Gynecology Division, University of Washington, Seattle, WA 98109, USA. Electronic address:

Background: Neovaginal ileitis is an understudied complication of intestinal vaginoplasty for which no evidence-based treatments exist. Mesalamine has been successfully reported to treat neovaginal colitis and has mixed evidence of efficacy in treating ileal inflammatory syndromes.

Case: We report a 29-year-old female with a history of ileal neovaginoplasty at two years of age for cloacal variant and treatment-refractory neovaginal ileitis with pain and bleeding whose symptoms resolved with treatment with topical mesalamine.

View Article and Find Full Text PDF

Introduction And Hypothesis: Sigmoid vaginoplasty is a safe and acceptable procedure for vaginal agenesis with good cosmetic results and acceptable complications rate. Sigmoid colon vaginoplasty is the treatment of choice because of its large lumen, thick walls resistant to trauma, adequate secretion allowing lubrication, not necessitating prolonged dilatation, and short recovery time. We investigate the feasibility, safety, and clinical therapeutic effect of laparoscopic sigmoid vaginoplasty in women with Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome.

View Article and Find Full Text PDF

Background: Sexual function in transgender adolescents after puberty suppression has been a topic of recent clinical and scientific questions.

Aim: This study aimed to explore the long-term effects of early treatment with puberty suppression on sexual functioning of transfeminine individuals after vaginoplasty.

Methods: This retrospective cohort study included 37 transfeminine individuals treated with a gonadotropin-releasing hormone agonist (puberty suppression), estrogen, and vaginoplasty (penile inversion technique or intestinal vaginoplasty) at the Center of Expertise on Gender Dysphoria in Amsterdam, the Netherlands, between 2000 and 2016.

View Article and Find Full Text PDF

Insights into the assembly of the neovaginal microbiota in Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome patients.

Nat Commun

September 2024

National Clinical Research Center for Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, State Key Laboratory for Complex Severe and Rare Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, No. 1 Shuaifuyuan, 100005, Beijing, China.

Article Synopsis
  • - Neovaginas can be surgically created for women with MRKH syndrome or during gender-affirming surgery, and studying their microbiota is essential for effective management.
  • - A longitudinal study showed that the neovaginal microbiota initially had random characteristics with an increase in Enterococcus faecalis and Mycoplasmas, but evolved to resemble a normal vagina within 6-12 months after surgery.
  • - By 2-4 years post-surgery, the neovaginal microbiota aligned more closely with pre-surgery microbiota, particularly with the presence of Lactobacillus crispatus, indicating its association with vaginal health and opportunities for enhancing its colonization.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!